AGENDA

Welcome & Introductions
8:00 - 8:15 am CT

Chris Prakash, MD 
Rural Health Expert Moderator
Medical Director
Texas Oncology - Paris

Evolving Treatment Paradigms in HER2-Expressing 
Metastatic Breast Cancer: Integrating the Latest Evidence
8:15 - 9:15 am CT | 1.0 CME/CE

Harold J. Burstein, MD, PhD
Professor of Medicine
Harvard Medical School
Medical Oncologist
Dana-Farber Cancer Institute

Chris Prakash, MD 
Medical Director
Texas Oncology - Paris

Managing Adverse Events Associated with Antibody Drug Conjugates
9:15 - 10:15 am CT | 1.0 CME/CE

Harold J. Burstein, MD, PhD
Professor of Medicine
Harvard Medical School
Medical Oncologist
Dana-Farber Cancer Institute

Chris Prakash, MD 
Medical Director
Texas Oncology - Paris

Break
10:15 - 10:30 am CT

Treatment for Advanced Endometrial Cancer:
Addressing Disparities to Improve Quality and Achieve Equity
10:30 - 11:30 am CT | 1.0 CME/CE

Brian M. Slomovitz, MD, MS, FACOG
Director, Gynecologic Oncology
Mount Sinai Medical Center
Professor, Obstetrics and Gynecology
Florida International University

Chris Prakash, MD
Medical Director
Texas Oncology - Paris

Bridging the Gap in Prostate Cancer Care: 
An Update on the Latest Advances
11:30 am - 12:30 pm CT | 1.0 CME/CE

Alicia K. Morgans, MD
Associate Professor, Medicine
Harvard Medical School
Medical Director, Survivorship Program, Oncology
Dana-Farber Cancer Institute

Chris Prakash, MD 
Medical Director
Texas Oncology - Paris

Evolving Treatment Paradigms in Hepatocellular Carcinoma: Applying the Latest Evidence
12:45 - 1:45 pm CT | 1.0 CME/CE

Ghassan K. Abou-Alfa, MD, MBA
Attending Physician
Memorial Sloan Kettering Cancer Center

Chris Prakash, MD
Medical Director
Texas Oncology - Paris

Agenda as of 11/15/23. Session order subject to change.